PROTARA THERAPEUTIC INC (TARA) Stock Analyst Earnings Estimates
NASDAQ:TARA - Nasdaq - US74365U1079 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.95M | -100.00% | 7.582M | 56.61M 646.64% | 67.832M 19.82% | 79.818M 17.67% | 123.17M 54.31% | 171.4M 39.16% | 237.04M 38.30% | |||||||||||
| EBITDA YoY % growth | -7.55M | N/A -175.63% | N/A -37.39% | N/A -5.67% | N/A 29.66% | N/A 29.55% | -32.538M -129.39% | N/A -37.94% | N/A 21.28% | N/A -16.04% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -7.58M | -20.918M -175.33% | -30.239M -37.57% | -33.181M -5.75% | -21.287M 29.61% | -19.681M 28.64% | -34.932M -125.84% | -52.186M -37.89% | -42.248M 20.95% | -45.73M -16.18% | -47.614M -9.17% | -58.098M -22.02% | -66.483M -14.43% | -43.258M 34.93% | -45.071M -4.19% | -23.257M 48.40% | 4.775M 120.53% | 36.009M 654.12% | 81.35M 125.92% | |
| Operating Margin | -256.95% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -876.85% | -76.41% | -66.44% | -29.14% | 3.88% | 21.01% | 34.32% | |
| EPS YoY % growth | N/A | -51.31 48.76% | -71.81 -32.06% | -91.94 0.00% | -46.21 34.10% | -17.94 33.88% | -3.32 84.31% | -4.51 10.99% | -3.55 5.23% | -3.64 10.53% | -3.14 11.93% | -3.33 -6.00% | -2.33 30.22% | -1.31 43.71% | -1.37 -4.42% | -0.74 45.52% | 0.15 120.55% | 1.13 640.00% | 2.52 122.52% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.60 33.51% | -0.64 34.10% | -0.66 -45.82% | -0.52 -4.72% | -0.54 10.23% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -13.82M -25.17% | -14.55M -22.77% | -14.955M -40.28% | -15.436M -25.19% | -16.027M -15.97% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.50 42.53% | -0.53 | 0.03 | 5.73% |
| Q2 2024 Q2Q % growth | -0.45 55.00% | -0.82 | 0.37 | 44.85% |
| Q1 2024 Q2Q % growth | -0.97 -21.25% | -0.94 | -0.03 | -3.37% |
| Q4 2023 Q2Q % growth | -0.90 41.94% | -0.94 | 0.04 | 3.83% |
| Q3 2023 Q2Q % growth | -0.87 -27.94% | -1.00 | 0.13 | 12.97% |
| Q2 2023 Q2Q % growth | -1.00 -25.00% | -0.89 | -0.11 | -12.04% |
| Q1 2023 Q2Q % growth | -0.80 16.67% | -0.89 | 0.09 | 10.57% |
| Q4 2022 Q2Q % growth | -1.55 -70.33% | -0.77 | -0.79 | -102.61% |
| Q3 2022 Q2Q % growth | -0.68 29.17% | -0.77 | 0.09 | 11.89% |
| Q2 2022 Q2Q % growth | -0.80 29.82% | -0.96 | 0.16 | 16.27% |
| Q1 2022 Q2Q % growth | -0.96 20.00% | -0.92 | -0.04 | -4.19% |
| Q4 2021 Q2Q % growth | -0.91 -106.82% | -0.96 | 0.05 | 5.42% |
| Q3 2021 Q2Q % growth | -0.96 23.81% | -1.03 | 0.07 | 6.81% |
| Q2 2021 Q2Q % growth | -1.14 6.56% | -1.07 | -0.07 | -6.19% |
| Q1 2021 Q2Q % growth | -1.20 33.70% | -0.74 | -0.46 | -61.90% |
| Q4 2020 Q2Q % growth | -0.44 82.75% | -1.23 | 0.79 | 64.28% |
| Q3 2020 Q2Q % growth | -1.26 60.63% | -1.51 | 0.25 | 16.72% |
| Q2 2020 Q2Q % growth | -1.22 88.70% | -1.87 | 0.65 | 34.64% |
| Q1 2020 Q2Q % growth | -1.81 86.69% | -1.84 | 0.03 | 1.69% |
| Q4 2019 Q2Q % growth | -2.55 | -2.20 | -0.35 | -16.01% |
| Q3 2019 Q2Q % growth | -3.20 | -3.67 | 0.47 | 12.85% |
| Q2 2019 Q2Q % growth | -10.80 | -6.94 | -3.86 | -55.71% |
| Q1 2019 Q2Q % growth | -13.60 | -9.18 | -4.42 | -48.15% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 32.31% | 0% | -0.65% |
| Revenue | N/A | N/A | N/A | N/A |